Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Alnylam Pharmaceuticals Inc (ALNY)  
$152.78 3.48 (2.33%) as of 4:30 Fri 6/7


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 123,030,000
Market Cap: 18.80(B)
Last Volume: 862,728 Avg Vol: 722,453
52 Week Range: $143.31 - $211.65
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  824
Guru Rank Value     : 0.5
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Alnylam Pharmaceuticals is a commercial-stage biopharmaceutical company developing therapeutics based on RNA interference. Co. has four RNAi-based medicines, ONPATTRO® (patisiran), GIVLAARI® (givosiran), OXLUMO™ (lumasiran) and Leqvio® (inclisiran). ONPATTRO is approved for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. GIVLAARI is approved for the treatment of adults with acute hepatic porphyria. Co. has approval for OXLUMO for the treatment of hyperoxaluria type 1 (PH1) in all age groups. Leqvio (inclisiran) is being developed for the treatment of adults with hypercholesterolemia or mixed dyslipidemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 21,700 98,555 124,204 268,793
Total Sell Value $3,224,546 $16,182,261 $20,937,886 $52,053,725
Total People Sold 1 8 9 10
Total Sell Transactions 1 13 19 36
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 748
  Page 5 of 30  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Greenstreet Yvonne President & COO   •       –      –    2021-12-22 4 D $186.55 $479,699 D/D (2,538) 13,902     -
   Vaishnaw Akshay President, R&D   •       –      –    2021-12-21 4 A $0.00 $0 D/D 5,417 16,632     -
   Maraganore John Chief Executive Officer   •       •      –    2021-12-21 4 A $0.00 $0 D/D 14,167 234,299     -
   Greenstreet Yvonne President & COO   •       –      –    2021-12-21 4 A $0.00 $0 D/D 5,417 16,440     -
   Maraganore John Chief Executive Officer   •       •      –    2021-12-10 4 OE $42.22 $399,829 D/D 5,367 220,132     -
   Maraganore John Chief Executive Officer   •       •      –    2021-11-12 4 AS $170.36 $5,827,801 D/D (33,978) 214,765 -5%     
   Maraganore John Chief Executive Officer   •       •      –    2021-11-12 4 OE $7.10 $241,244 D/D 33,978 248,743     -
   Maraganore John Chief Executive Officer   •       •      –    2021-08-13 4 AS $198.02 $6,788,196 D/D (33,979) 214,765 -1%     
   Maraganore John Chief Executive Officer   •       •      –    2021-08-13 4 OE $7.10 $241,251 D/D 33,979 248,744     -
   Vaishnaw Akshay President, R&D   •       –      –    2021-08-09 4 AS $200.00 $2,166,800 D/D (10,834) 11,215 -8%     
   Vaishnaw Akshay President, R&D   •       –      –    2021-08-09 4 OE $63.00 $682,542 D/D 10,834 22,049     -
   Greenstreet Yvonne President & COO   •       –      –    2021-08-06 4 AS $199.00 $10,559,736 D/D (53,064) 11,023 -2%     
   Greenstreet Yvonne President & COO   •       –      –    2021-08-06 4 OE $77.10 $4,091,234 D/D 53,064 64,087     -
   Keating Laurie EVP, Chief Legal Officer   •       –      –    2021-08-05 4 AS $188.95 $1,889,500 D/D (10,000) 5,132 -4%     
   Keating Laurie EVP, Chief Legal Officer   •       –      –    2021-08-05 4 OE $88.95 $889,500 D/D 10,000 15,132     -
   Keating Laurie EVP, Chief Legal Officer   •       –      –    2021-07-12 4 AS $178.95 $1,219,098 D/D (6,812) 5,132 -2%     
   Keating Laurie EVP, Chief Legal Officer   •       –      –    2021-07-12 4 OE $85.00 $598,770 D/D 6,812 11,944     -
   Vaishnaw Akshay President, R&D   •       –      –    2021-06-18 4 AS $175.00 $2,573,900 D/D (14,708) 11,215 12%     
   Vaishnaw Akshay President, R&D   •       –      –    2021-06-18 4 OE $42.22 $723,495 D/D 11,804 25,923     -
   Keating Laurie EVP, Chief Legal Officer   •       –      –    2021-06-09 4 AS $154.00 $267,036 D/D (1,734) 5,132 32%     
   Maraganore John Chief Executive Officer   •       •      –    2021-05-13 4 AS $128.30 $4,443,725 D/D (33,979) 214,765 37%     
   Maraganore John Chief Executive Officer   •       •      –    2021-05-13 4 OE $7.10 $241,251 D/D 33,979 248,744     -
   Vaishnaw Akshay President, R&D   •       –      –    2021-04-21 4 AS $135.41 $374,135 D/D (2,732) 14,119 48%     
   Vaishnaw Akshay President, R&D   •       –      –    2021-04-20 4 D $131.75 $309,983 D/D (2,351) 16,851     -
   Poulton Jeffrey V. Chief Financial Officer   •       –      –    2021-04-20 4 D $131.75 $182,347 D/D (1,383) 3,135     -
  748 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 30
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us